Variant report
Variant | esv3415767 |
---|---|
Chromosome Location | chr2:168368306-168370204 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:168342324..168343828-chr2:168369519..168372114,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs535891354 | chr2:168368306-168368307 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs377272322 | chr2:168368333-168368334 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs527288469 | chr2:168368363-168368364 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs188745334 | chr2:168368431-168368432 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs575767675 | chr2:168368439-168368440 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs545066996 | chr2:168368486-168368487 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs564947610 | chr2:168368493-168368494 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs572165896 | chr2:168368535-168368536 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs181689459 | chr2:168368540-168368541 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs561280351 | chr2:168368611-168368612 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs78929844 | chr2:168368615-168368616 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs549430844 | chr2:168368636-168368637 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs562845722 | chr2:168368645-168368646 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs531866247 | chr2:168368655-168368656 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs61195978 | chr2:168368682-168368683 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs551819720 | chr2:168368761-168368762 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs571760791 | chr2:168368766-168368767 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs73024058 | chr2:168368773-168368774 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs547672244 | chr2:168368774-168368775 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs75644299 | chr2:168368798-168368799 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs373281023 | chr2:168368817-168368818 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs536533756 | chr2:168368821-168368822 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs555768911 | chr2:168368850-168368851 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs575597086 | chr2:168368854-168368855 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs538363835 | chr2:168368994-168368995 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs191558493 | chr2:168369021-168369022 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs565429651 | chr2:168369033-168369034 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs67927245 | chr2:168369047-168369048 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs201554463 | chr2:168369056-168369057 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs68096314 | chr2:168369057-168369058 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs201685598 | chr2:168369066-168369067 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs200275833 | chr2:168369068-168369069 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs58191137 | chr2:168369070-168369071 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs145418656 | chr2:168369076-168369077 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs374423893 | chr2:168369077-168369078 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs72076744 | chr2:168369078-168369079 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs66968215 | chr2:168369079-168369080 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs199518665 | chr2:168369089-168369090 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs572042511 | chr2:168369091-168369092 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs375036584 | chr2:168369101-168369102 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs61380991 | chr2:168369102-168369103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs56166323 | chr2:168369103-168369104 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs368513086 | chr2:168369105-168369106 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs185966823 | chr2:168369106-168369107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs74171207 | chr2:168369115-168369116 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs60242658 | chr2:168369116-168369117 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs190838223 | chr2:168369117-168369118 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs563065865 | chr2:168369118-168369119 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs200504901 | chr2:168369129-168369130 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs541258735 | chr2:168369130-168369131 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Mental retardation | 22214275 | CNVD |
Glioblastoma | 21080181 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Autism | 18414403 | CNVD |
Developmental delay | 21147756 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neonatal seizures | 20384724 | CNVD |
severe myoclonic epilepsy of infancy | 18294202 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:168366600-168384800 | Weak transcription | H1 Cell Line | embryonic stem cell |
2 | chr2:168366800-168374200 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
3 | chr2:168367000-168385200 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
4 | chr2:168367200-168371200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
5 | chr2:168367200-168371200 | Weak transcription | Muscle Satellite Cultured Cells | -- |